vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Rimini Street, Inc. (RMNI). Click either name above to swap in a different company.
Rimini Street, Inc. is the larger business by last-quarter revenue ($105.5M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 1.1%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Rimini Street, Inc. is a global provider of independent third-party support services for enterprise software products including Oracle and SAP platforms. It serves clients across multiple industries worldwide, delivering cost-effective support, maintenance, and consulting solutions that help businesses cut operational expenses while ensuring software performance and security.
PBYI vs RMNI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $105.5M |
| Net Profit | — | $1.4M |
| Gross Margin | 69.3% | 59.0% |
| Operating Margin | 22.7% | 4.6% |
| Net Margin | — | 1.3% |
| Revenue YoY | 27.7% | 1.2% |
| Net Profit YoY | — | -59.4% |
| EPS (diluted) | $0.26 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $105.5M | ||
| Q4 25 | $75.5M | $109.8M | ||
| Q3 25 | $54.5M | $103.4M | ||
| Q2 25 | $52.4M | $104.1M | ||
| Q1 25 | $46.0M | $104.2M | ||
| Q4 24 | $59.1M | $114.2M | ||
| Q3 24 | $80.5M | $104.7M | ||
| Q2 24 | $47.1M | $103.1M |
| Q1 26 | — | $1.4M | ||
| Q4 25 | — | $724.0K | ||
| Q3 25 | $8.8M | $2.8M | ||
| Q2 25 | $5.9M | $30.3M | ||
| Q1 25 | $3.0M | $3.4M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | $20.3M | $-43.1M | ||
| Q2 24 | $-4.5M | $-1.1M |
| Q1 26 | — | 59.0% | ||
| Q4 25 | 69.3% | 60.4% | ||
| Q3 25 | 77.7% | 59.9% | ||
| Q2 25 | 76.5% | 60.4% | ||
| Q1 25 | 77.1% | 61.0% | ||
| Q4 24 | 76.4% | 63.7% | ||
| Q3 24 | 63.9% | 60.7% | ||
| Q2 24 | 77.4% | 59.1% |
| Q1 26 | — | 4.6% | ||
| Q4 25 | 22.7% | 4.5% | ||
| Q3 25 | 17.6% | 4.2% | ||
| Q2 25 | 12.7% | 39.6% | ||
| Q1 25 | 8.7% | 9.0% | ||
| Q4 24 | 22.6% | 13.0% | ||
| Q3 24 | 27.4% | -47.4% | ||
| Q2 24 | -4.6% | -0.8% |
| Q1 26 | — | 1.3% | ||
| Q4 25 | — | 0.7% | ||
| Q3 25 | 16.2% | 2.7% | ||
| Q2 25 | 11.2% | 29.1% | ||
| Q1 25 | 6.5% | 3.2% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | 25.2% | -41.2% | ||
| Q2 24 | -9.6% | -1.1% |
| Q1 26 | — | $0.01 | ||
| Q4 25 | $0.26 | $0.00 | ||
| Q3 25 | $0.17 | $0.03 | ||
| Q2 25 | $0.12 | $0.32 | ||
| Q1 25 | $0.06 | $0.04 | ||
| Q4 24 | $0.40 | $0.07 | ||
| Q3 24 | $0.41 | $-0.47 | ||
| Q2 24 | $-0.09 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $132.2M |
| Total DebtLower is stronger | $22.7M | $56.4M |
| Stockholders' EquityBook value | $130.3M | — |
| Total Assets | $216.3M | $397.1M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $132.2M | ||
| Q4 25 | $97.5M | $120.0M | ||
| Q3 25 | $94.4M | $108.7M | ||
| Q2 25 | $96.0M | $101.3M | ||
| Q1 25 | $93.2M | $122.6M | ||
| Q4 24 | $101.0M | $88.8M | ||
| Q3 24 | $96.7M | $119.5M | ||
| Q2 24 | $96.8M | $134.2M |
| Q1 26 | — | $56.4M | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $130.3M | $-27.0M | ||
| Q3 25 | $115.3M | $-27.3M | ||
| Q2 25 | $104.7M | $-29.0M | ||
| Q1 25 | $97.1M | $-63.7M | ||
| Q4 24 | $92.1M | $-69.4M | ||
| Q3 24 | $71.1M | $-76.8M | ||
| Q2 24 | $48.5M | $-36.1M |
| Q1 26 | — | $397.1M | ||
| Q4 25 | $216.3M | $423.1M | ||
| Q3 25 | $202.9M | $352.9M | ||
| Q2 25 | $194.9M | $397.5M | ||
| Q1 25 | $196.2M | $343.0M | ||
| Q4 24 | $213.3M | $369.1M | ||
| Q3 24 | $220.7M | $343.8M | ||
| Q2 24 | $205.0M | $367.4M |
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | — |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $19.6M | ||
| Q3 25 | $9.7M | $24.7M | ||
| Q2 25 | $14.1M | $-17.8M | ||
| Q1 25 | $3.6M | $33.7M | ||
| Q4 24 | $15.6M | $-37.7M | ||
| Q3 24 | $11.0M | $-18.5M | ||
| Q2 24 | $1.0M | $6.3M |
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $18.9M | ||
| Q3 25 | $9.7M | $23.5M | ||
| Q2 25 | $14.1M | $-19.5M | ||
| Q1 25 | $3.6M | $32.8M | ||
| Q4 24 | $15.6M | $-38.4M | ||
| Q3 24 | $11.0M | $-19.2M | ||
| Q2 24 | $1.0M | $5.4M |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 17.2% | ||
| Q3 25 | 17.7% | 22.7% | ||
| Q2 25 | 26.8% | -18.8% | ||
| Q1 25 | 7.7% | 31.5% | ||
| Q4 24 | 26.4% | -33.6% | ||
| Q3 24 | 13.7% | -18.3% | ||
| Q2 24 | 2.1% | 5.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.0% | 1.2% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.02× | ||
| Q3 25 | 1.10× | 8.94× | ||
| Q2 25 | 2.41× | -0.59× | ||
| Q1 25 | 1.21× | 10.06× | ||
| Q4 24 | — | -5.66× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
